Kidney cancer, Renal cell cancer
Results
Phase 2
This trial looked at a drug called axitinib (Inlyta) for people with kidney cancer (renal cell cancer) that had spread to another part of the body (advanced).
This trial was supported by Cancer Research UK.
Recruitment start: 1 October 2012
Recruitment end: 23 December 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr James Larkin
The Institute of Cancer Research (ICR)
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Pfizer
The Royal Marsden NHS Foundation Trust
This is Cancer Research UK trial number CRUKE/11/061.
Last reviewed: 27 February 2018
CRUK internal database number: 8285
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
